Effect of administration of a synbiotic (Enterococcus faecium and agave inulin) on cognitive impairment in elderly adults
Natalia Rojas-Sánchez , Adela Escandón-Cesarman , Emilio Moreno-González , Oscar Mario Delgado-Casillas , Andrea P. Ibarra García , Ivan Ignacio-Mejía , Exsal Manuel Albores-Mendez , Marco Antonio Vargas-Hernandez , Martha Patricia Hernandez-Valdez , Paulina Romaña-Espiritu , Silvia G. Sanchez-Ávila , María E. Sanchez-Hernandez , Antonio Ibarra
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004156
Aim: To assess the effect of a synbiotic supplement composed of Enterococcus faecium and agave inulin on cognitive function in older adults with mild cognitive impairment (MCI). Methods: In a triple-blind randomized crossover trial, nineteen adults aged 64–85 years with MCI received either the synbiotic or an isocaloric vehicle for eight weeks, followed by a three-week washout and treatment crossover. Cognitive outcomes were assessed at baseline, after the first intervention, and after crossover using the Modified Mini-Mental State Examination (MMSE), Rey-Osterrieth Complex Figure Test (RCFT; copy and memory), and Abbreviated Instrument for Expectations of Self-Efficacy for Daily Activities in Older Adults (AERAC) self-efficacy scale. Paired and unpaired Student’s t-tests were used for statistical comparisons (p < 0.05). Results: The synbiotic group showed significant improvement relative to baseline across all domains: MMSE (p = 0.05), AERAC (p = 0.005), RCFT-copy (p = 0.03), and RCFT-memory (p = 0.03). Post-treatment comparisons between groups also favored the synbiotic, with significant differences in MMSE (p = 0.001), AERAC (p = 0.001), RCFT-copy (p = 0.0095), and RCFT-memory (p = 0.001). After crossover, cognitive gains were sustained and reproduced. MMSE scores reached 17.89 ± 1.45 in the synbiotic-first group versus 18.20 ± 0.63 in the control-first group (p < 0.001). RCFT-copy remained high (29.83 ± 4.18 vs. 29.52 ± 5.60, p = 0.0157), while RCFT-memory scores differed (17.56 ± 6.73 vs. 17.20 ± 3.29, p = 0.0005). AERAC scores continued to improve during crossover (82.60 ± 10.49 vs. 85.46 ± 8.28, p < 0.001). No adverse effects occurred. Conclusions: Synbiotic supplementation significantly improved global cognition, visuoconstructive ability, memory, and functional self-efficacy in older adults with MCI. Benefits persisted beyond the initial intervention and were replicated when the control group received the synbiotic, supporting its potential as a safe and effective strategy to mitigate age-related cognitive decline.
aging / cognitive impairments / gut-brain axis / synbiotic supplementation
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
Landefeld CS, editor. CURRENT Geriatric Diagnosis and Treatment. New York: McGraw-Hill Professional; 2004. |
| [6] |
|
| [7] |
|
| [8] |
United Nations. World Population Ageing 2023: Challenges and opportunities of population ageing in the least developed countries [Internet]. New York: United Nations; c2023 [cited 2026 Jan 6]. Available from: https://www.un.org/development/desa/pd/content/world-population-ageing-2023 |
| [9] |
|
| [10] |
World Health Organization. Dementia [Internet]. Geneva: WHO; c2026 [cited 2026 Jan 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia |
| [11] |
|
| [12] |
Proyecciones de la población de México 2010-2050 [Internet]. México: CONSEJO NACIONAL DE POBLACIÓN; c2012 [cited 2025 Nov 22]. Available from: http://www.conapo.gob.mx/work/models/CONAPO/Resource/1529/2/images/DocumentoMetodologicoProyecciones2010_2050.pdf |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
Gibson GR, |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
Clarke G, |
| [33] |
|
| [34] |
|
| [35] |
Holzapfel W, Arini A, Aeschbacher M, Coppolecchia R, |
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
/
| 〈 |
|
〉 |